Breakthrough findings demonstrate a possible target and potential drug treatment to restore memory loss and extend life span in mice with neurodegeneration
“We have treated mice with a new type of drug, and found that these drugs can not only improve symptoms of brain degeneration, such as cognitive decline, but can also extend the life-span of these terminally-sick mice. Our study opens up avenues for researchers to look at new drugs that treat the symptoms of Alzheimer’s and also slow disease progression”
– Professor Andrew Tobin
An international team of scientists has announced a new advance in the fight against Alzheimer’s disease by identifying a new drug target for not only improving symptoms of brain degeneration – but also to extend the life-span of the terminally ill mice.
The four-year study by Medical Research Council (MRC) scientists based at the MRC Toxicology Unit at the University of Leicester is published in the Journal of Clinical Investigation. The study was led by Professor Andrew Tobin alongside colleagues from pharmaceutical company Eli Lilly and Company and the Monash Institute for Pharmaceutical Sciences in Australia. The project was also partly supported by the Wellcome Trust.
Corresponding author Professor Tobin, who alongside the lead researcher Dr Sophie Bradley has since moved from the University of Leicester to the University of Glasgow, said: “The paper describes drug-like molecules that can restore memory loss and slow progression of prion neurodegenerative disease in a manner that relates to the potential of these drugs in human Alzheimer’s disease.
“We have been using mice whose brain cells are progressively dying, similar to what happens in Alzheimer’s disease. This project focuses on a particular protein in the brain, which is proposed to be involved in Alzheimer’s disease, and as such could be a potential target for new drugs.
“We have treated mice with a new class of drug, and found that these drugs can not only improve symptoms of brain degeneration, such as cognitive decline, but can also extend the life-span of these terminally-sick mice.”
The researchers state that drugs which activate this protein receptor in the brain have previously been tested in clinical trials for Alzheimer’s disease, and showed positive results with respect to improving cognition, but the patients experienced a large number of adverse side effects. This new class of drug is more selective and does not cause any side-effects when administered to mice in the study.
The study authors believe that this offers hope in the design of new drugs for improving cognition and extending life span.
Professor Tobin said: “This work may provide important information as to whether this protein is a viable drug target in the treatment of diseases associated with the progressive death of brain cells. This is of great importance to society, based on the fact that the treatment options for Alzheimer’s disease are very limited – there are no cures for Alzheimer’s disease and current treatments are focused on relieving some of the symptoms.
“What we have found is a novel class of drugs, called allosteric ligands, that target a protein called the M1 muscarinic receptor, which is present in the brain. Activating this receptor protein can not only improve cognitive function in mice with progressive brain degeneration, but when administered daily, can extend life span.”
The scientists say the work is important because it focuses on identifying a treatment that not only improves symptoms associated with neurodegeneration, like current treatments, but also identifies a new strategy for slowing disease progression and extending life-span.
Professor Tobin said: “Alzheimer’s disease is the most common form of dementia, and it affects an estimated 850,000 people in the UK alone. There are no treatments that can slow or halt the progression of Alzheimer’s, and patients are treated with drugs which temporarily mask the symptoms of the disease. Often these treatments are associated with side-effects which can limit patient compliance.
“I am proud to be involved in a collaboration with researchers across the world to address one of the world’s major healthcare challenges. Our study opens up avenues for researchers to look at new drugs that treat the symptoms of Alzheimer’s and also slow disease progression.”
[osd_subscribe categories=’alzheimers’ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “ALZHEIMERS”‘]
Receive an email update when we add a new ALZHEIMERS article.
The Latest on: Alzheimer’s
[google_news title=”” keyword=”Alzheimer’s” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Alzheimer’s
- Exercise could help predict your likelihood of getting neurological diseases like Alzheimer'son February 28, 2024 at 4:25 am
A brain expert has shared an exercise people can do that helps determine their likelihood of potentially developing neurological diseases - such as Alzheimer's and dementia. Explaining all on the ...
- Promising Pathways to Simplified Alzheimer's Diagnosis Unveiled in Groundbreaking Studyon February 28, 2024 at 4:00 am
Washington D.C., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Washington D.C., Feb. 28, 2024- The Global Alzheimer’s Platform Foundation ®, (GAP) is releasing the first results from the Bio-Hermes-001 Study.
- Belly fat tied to brain health in middle-aged adults at high risk of Alzheimer’s, study finds—but it’s worse for menon February 28, 2024 at 2:00 am
The amounts of fat in the liver, abdomen, and pancreas impact cognitive function and regional brain volumes, Rutgers Health researchers say.
- Fox News Links Joe Biden's Ice Cream Habit to Alzheimer'son February 28, 2024 at 1:26 am
Fox News host Jesse Watters has linked President Joe Biden's love of ice cream to Alzheimer's disease.Watters made the comments after the president spoke to reporters while eating ice cream after ...
- Fox News Host Links Biden’s Love of Ice Cream to Alzheimer’s Disease: ‘You See What’s Going on Here?’on February 27, 2024 at 10:20 pm
The host then drew a parallel between Biden and Alzheimer’s patients: You know who lights up for ice cream? Children and the elderly. There’s a reason caregivers deliver ice cream to their patients in ...
- Researchers make precious headway into a genetic form of Alzheimer's diseaseon February 27, 2024 at 12:49 pm
UC Santa Barbara researchers and collaborators in Colombia, Brazil and Germany are progressing toward an understanding of mechanisms that underlie Alzheimer's disease, in particular an early-onset, ...
- Excess fat around pancreas linked to higher risk for Alzheimer'son February 27, 2024 at 11:31 am
It's well known that obesity is a risk factor for lower cognitive functioning and higher dementia risk, the team said, but the role of gender has been less clear. The new study suggests men are more ...
- Possible Alzheimer's disease treatment breakthrough: UNC researchers focus on amyloid plaqueon February 27, 2024 at 7:01 am
CHAPEL HILL, N.C. (WTVD) -- A research team at UNC is studying how amyloid plaque forms in the brain of Alzheimer's patients in hopes of developing breakthrough treatments for the disease. "When we ...
- Love and Alzheimer's collide in Oscar-nominated 'Eternal Memory'on February 26, 2024 at 5:29 pm
As a journalist, Augusto Gongora fought to chronicle Chile's violent military dictatorship.- 'I'm no longer here' - As a journalist, Gongora had built his career in front of cameras.
via Bing News